SETD2 and nonpapillary renal cell carcinoma: Previous evidences showed that loss of H3K36me3 demethylase SETD2 due to genomic alterations and hypermethylation was identified in both primary and metastases of ccRCC [15], while decreased methylation in regional H3K36me3 was only observed in lesions of distant metastases [28].